Methylphenidate for Apathy in Alzheimer Disease-Why Should We Care?

JAMA Neurol. 2021 Nov 1;78(11):1311-1313. doi: 10.1001/jamaneurol.2021.2942.

Author

Carolyn Fredericks¹

Affiliation

¹ Department of Neurology, Yale University, New Haven, Connecticut.

PMID: 34570178
DOI: 10.1001/jamaneurol.2021.2942

No abstract available

Publication types

Comment

MeSH terms

Alzheimer Disease* / drug therapy
Apathy*
Central Nervous System Stimulants* / therapeutic use
Double-Blind Method
Humans
Methylphenidate* / therapeutic use

Substances

Central Nervous System Stimulants
Methylphenidate